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Orthopedic surgical procedures based on the use of conventional biological graft tis-
sues are often associated with serious post‐operative complications such as immune
rejection, bacterial infection, and poor osseointegration. Bioresorbable bone graft
substitutes have emerged as attractive alternatives to conventional strategies
because they can mimic the composition and mechanical properties of the native
bone. Among these, bioactive glasses (BGs) hold great potential to be used as bioma-
terials for bone tissue engineering owing to their biomimetic composition and high
biocompatibility and osteoinductivity. Here, we report the development of a novel
composite biomaterial for bone tissue engineering based on the incorporation of a
modified strontium‐ and lithium‐doped 58S BG (i.e., BG‐5/5) into gelatin
methacryloyl (GelMA) hydrogels. We characterized the physicochemical properties
of the BG formulation via different analytical techniques. Composite hydrogels were
then prepared by directly adding BG‐5/5 to the GelMA hydrogel precursor, followed
by photocrosslinking of the polymeric network via visible light. We characterized the
physical, mechanical, and adhesive properties of GelMA/BG‐5/5 composites, as well
as their in vitro cytocompatibility and osteoinductivity. In addition, we evaluated the
antimicrobial properties of these composites in vitro, using a strain of methicillin‐
resistant Staphylococcus Aureus. GelMA/BG‐5/5 composites combined the functional
characteristics of the inorganic BG component, with the biocompatibility, biodegrad-
ability, and biomimetic composition of the hydrogel network. This novel biomaterial
could be used for developing osteoinductive scaffolds or implant surface coatings
with intrinsic antimicrobial properties and higher therapeutic efficacy.
KEYWORDS
antimicrobial, bioactive glass, bioadhesive, bone tissue engineering, orthopedic biomaterials,
osteoinductiveJ Tissue Eng Regen Med. 2020;14:66–81.wileyonlinelibrary.com/journal/term
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More than two million bone grafts are performed worldwide each year
for surgical procedures in traumatology, orthopedics, oncology, and
dentistry (Ho‐Shui‐Ling et al., 2018). Although biological tissues such
as autografts, allografts, and xenografts still constitute the most com-
mon sources for bone grafts, they are often hindered by their high cost,
low availability, and other technical limitations (Campana et al., 2014).
Furthermore, orthopedic surgical procedures are still largely associated
with serious post‐operative complications such as hemorrhages, sepsis,
immune rejection, and other comorbidities (Oryan, Alidadi, Moshiri, &
Maffulli, 2014). Because of this, bioresorbable bone graft substitutes
have emerged as attractive alternatives to circumvent the disadvan-
tages associated with conventional approaches for bone augmentation
and skeletal repair (Black et al., 2015). In recent years, bone tissue engi-
neering (TE) has emerged as an attractive strategy for the development
of bioresorbable bone graft substitutes (Ho‐Shui‐Ling et al., 2018).
However, the clinical translation of TE‐based approaches is often
impaired due to biological safety concerns associated with the use of
exogenous growth factors and cells.
Bone is a complex and highly dynamic form of connective tissue
that can regenerate and remodel itself through the combined action
of different cell types, such as osteoblasts, osteoclasts, and osteo-
cytes. This is mainly because the bone marrow contains a substantial
population of mesenchymal stem cells with high osteogenic potential,
which can migrate to the site of injury and differentiate to repair the
injured tissues (Lin et al., 2017). In addition, bone has a highly special-
ized extracellular matrix (ECM) that heavily influences lineage commit-
ment and stem cell fate (Benders et al., 2013). Biologically inspired
biomaterials have been developed based on the functionalization of
implant surfaces and bioengineered scaffolds with ECM‐derived bio-
molecules. Different types of osteoconductive biomaterials, such as
hydroxyapatite (HA), calcium phosphates (CaPs), and bioactive glasses
(BGs) have been shown to enable the nucleation and growth of CaP
crystals both in vitro and in vivo (Martin & Bettencourt, 2018). Among
these, BGs possess comparatively higher bioactivity than HA and
CaPs, owing to their high surface reactivity and their ionic dissolution
products in aqueous environments (Ciraldo, Boccardi, Melli,
Westhauser, & Boccaccini, 2018). The calcification capacity of these
inorganic materials enables the formation of an interfacial layer, which
creates a firm bond with the host bone that enhances
osseointegration at the implant site (Gkioni, Leeuwenburgh, Douglas,
Mikos, & Jansen, 2010). Furthermore, BGs in physiological fluids orig-
inate local increases in osmotic pressure and pH due to leaching of
ions from the surface, which in turn creates a hostile microenviron-
ment that prevents the growth of a wide range of aerobic and anaer-
obic bacteria (Drago, Toscano, & Bottagisio, 2018). However, despite
the remarkable properties of BGs, their implementation as scaffolding
materials for bone TE is limited due to their intrinsic brittleness and
low fracture toughness.
Hydrogels are three‐dimensional (3D) networks comprised of
hydrophilic polymers that are crosslinked to form matrices with highly
tunable physical properties (Bai et al., 2018). Hydrogel‐based scaffoldsconsist of an interconnected macroporous network that promotes the
attachment, proliferation, and differentiation of cells. However, due to
the biomechanical requirements of osseous tissues, TE scaffolds for
orthopedic applications often need to possess high mechanical stiff-
ness to mimic the load bearing properties and functionality of the
native bone (Portillo‐Lara, Shirzaei Sani, & Annabi, 2017; Shirzaei Sani
et al., 2018). The incorporation of inorganic materials into soft hydro-
gel matrices could be used to enhance their mechanical performance
and to deliver bioactive cues that promote scaffold mineralization
(Turnbull et al., 2018). Although previous groups have reported the
integration of different formulations of BGs into highly
cytocompatible hydrogels (Negahi Shirazi et al., 2016), the use of toxic
crosslinkers or ultraviolet light for polymerization has been associated
with numerous biosafety concerns (Wang et al., 2015). Here, we
aimed to engineer composite hydrogels with intrinsic bioactivity and
tunable physicochemical properties, which could help minimize the
adverse effects associated with conventional bone grafting strategies.
For this, we developed composite hydrogels based on the incorpora-
tion of a novel strontium (Sr)‐ and lithium (Li)‐doped BG (i.e., BG‐5/
5) into a visible light‐activated gelatin methacryloyl (GelMA) hydrogel.
We characterized the physical, mechanical, and adhesive properties, as
well as the in vitro cytocompatibility, bioactivity, and antimicrobial
properties of the composites. Our results highlight the remarkable
potential of GelMA/BG‐5/5 hydrogels for the development of multi-
functional scaffolds with intrinsic osteoinductive and antimicrobial
properties for bone TE.2 | METHODS
2.1 | Synthesis of Sr‐ and Li‐doped BG‐5/5
Tetraethyl orthosilicate (Si [OC2H5]4), triethylphosphate (PO
[OC2H5]3), calcium nitrate Ca (NO3)2,4H2O, strontium nitrate Sr
(NO3)2, and lithium nitrate LiNO3 were used as the source for silicon,
phosphorus, calcium, strontium, and lithium, respectively. A Sol‐Gel
method was used to synthesize SiO2‐CaO‐P2O5‐SrO‐Li2O BG with
different compositions (Table S1). For the synthesis of 25 g 60SiO2‐
26CaO‐4P2O5‐5SrO‐5Li2O (mol. %), an acidic medium was prepared
by mixing 116.96 cm3 of de‐ionized water with 19.50 cm3 of nitric
acid (0.1 N) on a magnetic stirrer at 250 rpm for 30 min. To prepare
a transparent solution, 53.165 cm3 of tetraethyl orthosilicate
(SiC8H20O4, Merck) was added to the mixture and stirred for 1 hr.
After this, 5.4135‐cm3 triethyl phosphate (C6H15O4P, Merck) was
added to the mixture dropwise and stirred for 1 hr. To generate the
colloidal solution (Sol), 24.371‐g calcium nitrate tetrahydrate (Ca
[NO3]2.4H2O, pure, Merck), 4.200‐g strontium nitrate (Sr [NO3]2,
Merck), and 2.737‐g lithium nitrate(Li [NO3], ≥99%, Sigma‐Aldrich)
were slowly added to the solution at 45 min intervals, for complete
dissolution of the nitrate salt. The final mixture was stirred for 1 hr,
which resulted in a homogenous and transparent Sol. To form the
integrated network (gel), the synthesized Sol was poured into a Pyrex
container and incubated at 37°C for 3 days. The gel was then heated
MOGHANIAN ET AL.68to 75°C for 3 days to completely remove residual water, making small
holes on the lid of the container to allow the escape of the gases gen-
erated by the reaction. Afterwards, the resulting gels were milled in a
planetary ball mill before being stabilized for 3 hr at 650°C with a
heating rate of 5°C/min, to remove the residual nitrate and organic
compounds. Lastly, the stabilized powders were cooled down in a fur-
nace at a rate of 5°C/min.2.2 | Analytical and biological characterization of
BG‐5/5.
Differential thermal analysis and thermogravimetric analysis of dried
gels were carried out using a Shimadzu DSC‐50 apparatus to evaluate
phase transitions as a function of temperature (from room temperature
up to 1,100°C) in a platinum crucible, under a N2 atmosphere (50 ml/
min) at a constant rate of 10°C/min. In addition, to analyze changes in
phase composition before and after soaking in simulated body fluid
(SBF), X‐ray diffraction (XRD; INEL‐Equinox‐3000, France) was per-
formed on BGs surfaces by applying a Cu Kα X‐ray at 40 kV, at a
wavelength of 0.15406 nm and in a 2θ range of 20–50°. In addition,
Fourier‐transform infrared (FTIR) spectroscopy (Nicolet Avatar 660)
was used to evaluate the apatite phase formation on the surface of
specimens, using a wavenumber range of 400–4,000 cm−1. The disk‐
shapedBGswere soaked in SBF at 37°C for 1, 3, 7, and 14 days. The ratio
of the sample surface area to the SBF volumewas 0.1 cm2·ml−1. The con-
centrations ofCa, Si, P, Sr, andLi ions in SBF solutionweredeterminedvia
ICP‐OES (Varian Vista Pro, Palo Alto, USA), at specific immersion time
periods based on chemical changes of the BGs (O'Donnell & Hill, 2010).
To evaluate the viability and proliferation of MC3T3‐E1, cells were
seeded on the surface of BG samples, and commercial MTT assays
(Sigma) were carried out at days 1, 3, and 7 post‐seeding according
to instructions from the manufacturer. Osteoblastic activity was eval-
uated on days 1, 3, and 7 using MC3T3‐E1 cells at a density of 1 × 104
cells/cm2 and a commercial alkaline phosphatase (ALP) kit (Sigma)
according to instructions from the manufacturer. Pristine BG samples
and cells grown in the absence of BG were used as controls.2.3 | Synthesis of GelMA/BG‐5/5 composites
First, GelMA was prepared by dissolving type A porcine skin gelatin at
10% (w/v) in Dulbecco's phosphate buffered saline (DPBS, GIBCO) at
60°C followed by adding 8% methacrylic anhydride according to the
procedures explained previously (Sani et al., 2019). To form
GelMA/BG‐5/5 composites, we incorporated both GelMA and BG‐
5/5 into a single polymeric network using a visible light‐activated
photoinitiator system (Sani, Lara, et al., 2019). Briefly, 10% (w/v)
GelMA was mixed with a solution containing triethanolamine (1.88%
[w/v]), N‐vinyl caprolactam (1.25% [w/v]), and Eosin Y disodium salt
(0.5 mM). Lastly, varying concentrations of BG‐5/5 (1, 5, 10, and
20% [w/v]) were physically mixed into the precursor solutions
followed by photocrosslinking of the hydrogels at 100 mW·cm−2,
using a xenon Genzyme Biosurgery light source (450 to 550 nm).2.4 | In vitro swellability, degradation and SEM
analysis
Cylindrical GelMA/BGs‐5/5 hydrogels (1, 5, 10, and 20% [w/v]) were
first formed as described above and lyophilized. The swelling ratio
(SR) of the composites was evaluated by incubating the samples in
DPBS at 37°C for 24 hr and then determining the changes relative
to the initial dry weight using the following formula:
SR ¼ Ws −W0
W0
where Ws and W0 correspond to the swollen and initial dry weights of
the hydrogels, respectively (Noshadi, Hong, et al., 2017). The degrada-
tion of the hydrogels was evaluated following incubation in 1 ml DPBS
supplemented with 10% FBS at 37°C for 3 weeks. The percentage
degradation at time t (Dt%) was calculated at days 1, 3, 7, 14, and
21, using the following formula:
Dtð Þ ¼ Wi −WtWi × 100%
where Wi and Wt correspond to the dry weight before and after incu-
bation for time t, respectively.
The BG particle distribution within the hydrogel network was visu-
alized using a Hitachi S‐4800 scanning electron microscope (SEM)
(10 kV). For this, the cylindrical GelMA/BG‐5/5 samples (7‐mm diam-
eter, 2‐mm height) were prepared, freeze‐dried, and gold/palladium
(Au/Pd)‐ coated prior to visualization.
2.5 | Mechanical characterization
Hydrogels were formed using varying concentrations of BG‐5/5 (1,
5, 10, and 20% [w/v]) as described above. An Instron 5542 universal
mechanical tester was used to evaluate the mechanical properties of
the constructs (Annabi, Rana, et al., 2017; Noshadi, Hong, et al.,
2017). Briefly, polydimethylsiloxane molds were used to form
GelMA/BGs compression test samples (cylindrical; diameter: 7 mm,
height: 4 mm) as well as tensile samples (rectangular; length:
12.00 mm, width: 5.00 mm, depth: 1.5 mm). For the tensile tests,
rectangular GelMA/BGs hydrogels were loaded between two tensile
grips and pulled at a rate of 0.5 mm/min until fracture. For
compression tests, cylindrical GelMA/BGs were placed between
two compression plates and compressed at a rate of 0.5 mm/min.
The compressive modulus was determined as the slope of the linear
portion of the stress‐strain curve between 0 mm/mm and 0.1 mm/
mm compressive strain. Results were reported as average and
standard deviation, and at least four specimens were analyzed per
group.
2.6 | Adhesive properties
Hydrogels were synthesized using varying concentrations of BG‐5/5
(1, 5, 10, and 20% [w/v]) as described above. The shear strength of
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F2255‐05 standard test (Annabi, Zhang, et al., 2017). Briefly, compos-
ites were formed in situ by pipetting 10 μl of the precursors between
two pieces of gelatin‐coated glass slides followed by photocrosslinking
via visible light. The samples were then placed between the clamps of
the Instron mechanical tester and pulled apart at a strain rate of
10 mm·min−1. Shear strength was calculated at the point of detaching.
The commercially available sealant Evicel® (Ethicon) was used as
a control.
Wound closure was measured using a modified ASTM F2458‐05
standard test (Annabi, Rana, et al., 2017). For this, porcine bone and
skin tissues (strips; length: 20.00 mm, width: 10.00 mm, depth:
2 mm) were used as biological substrates. The composites were
photocrosslinked between the tissue samples, and the adhesive
strength was recorded at the point of tearing at strain rate of
1 mm·min−1 using an Instron mechanical tester. The commercially
available sealant Evicel® (Ethicon) was used as a control.2.7 | In vitro cytocompatibility
For 2D cell seeding, hydrogels with different concentrations of BG‐5/
5 (i.e. 1, 5, and 10%) were formed using 8 μl of the precursor solution
on 3‐(trimethoxysilyl) propyl methacrylate‐coated slides and
photocrosslinked using visible light for 120 s (Noshadi, Hong, et al.,
2017). MC3T3 cells were then seeded on top of the hydrogels at a
concentration of 2 × 106 cell/ml and maintained in complete
alpha‐MEM media. For 3D encapsulation, MC3T3 cells were
encapsulated in 8‐μl hydrogels on 3‐(trimethoxysilyl) propyl
methacrylate‐coated slides at a density of 5 × 106 cell/ml (Noshadi,
Walker, et al., 2017).
Cell viability, spreading, and metabolic activity were determined
using a commercial LIVE/DEAD assay (Invitrogen), fluorescent
F‐actin/DAPI staining, and a commercial PrestoBlue kit (Fisher),
respectively, at days 1, 3, and 5 (Fares et al., 2018; Soucy et al.,
2018). Fluorescent images were acquired using a Zeiss Axio
Observer Z1 inverted microscope and analyzed with the ImageJ
software (NIH).2.8 | Osteogenic differentiation of MC3T3‐M1 cells
MC3T3‐M1 preosteoblasts were cultured using standard growth
media (i.e., α‐MEM with nucleosides and no ascorbic acid
[Invitrogen], supplemented with 10% FBS [Invitrogen], and 1%
penicillin/streptomycin [Invitrogen]). After trypsinization, MC3T3‐M1
cells were counted and encapsulated inside the hydrogels at a density
of 4 × 107 cells/ml. Briefly, the hydrogel precursor (with and without
the addition of 5% [w/v] BG‐5/5) was pipetted directly on top of
the pelleted cells and mixed thoroughly to obtain a homogeneous cell
suspension; 100 μl of the precursor suspension was sandwiched
between two glass slides using two 2‐mm spacers and
photocrosslinked as described before. Free‐floating cylindrical
hydrogels were maintained using three different culture protocols:(a) 10% (w/v) GelMA hydrogels suspended in standard growth media,
(b) 10% (w/v) GelMA hydrogels suspended in growth media supple-
mented with 300 ng/ml of bone morphogenetic protein 2 (BMP‐2;
Gibco), and (c) 10% (w/v) GelMA and 5% BG‐5/5 hydrogels suspended
in standard growth media. Cell‐free GelMA and GelMA/BG hydrogels
were also prepared for reference. Hydrogels were maintained in cul-
ture for up to 3 weeks, with two intermediate 1‐week and 2‐week
endpoints.
At the end of each endpoint, hydrogels were carefully harvested,
washed thrice with DPBS, and fixed with 4% paraformaldehyde for
histological evaluation. For this, 10‐μm transversal cryosections were
prepared (Noshadi, Walker, et al., 2017) and stained using Alizarin
red S (Millipore, 2%, pH 4.2) for 2 min, according to instructions from
the manufacturer. The differences in the extent of scaffold mineraliza-
tion were quantitated via threshold analysis of the micrographs using
the ImageJ software. The color threshold was set using pristine GelMA
scaffolds, which were cultured and processed in parallel with cell‐
laden GelMA and GelMA/BG hydrogels.2.9 | Antimicrobial activity
A LIVE/DEAD® BacLight™ kit (ThermoFisher) was used to determine
the viability of methicillin‐resistant Staphylococcus aureus (MRSA) in
hydrogels containing 1 and 5% BG‐5/5, according to instructions from
the manufacturer and following a methodology described in our previ-
ous publication (Shirzaei Sani, et al., 2018). The samples were imaged
using a Zeiss Axio Observer Z1 inverted microscope.2.10 | Statistical analysis
Data were analyzed using either one‐way or two‐way ANOVA tests
with the GraphPad Prism 7.0 softwareand were reported as the
mean ± standard deviation (*p < .05, **p < .01, and ***p < .001).3 | RESULTS
3.1 | Thermal characterization and X‐ray diffraction
analysis
The differential thermal analysis (Figure S1a) and thermogravimetric
analysis (Figure S1b) of BG‐5/5 showed the first endothermic peak
appeared at approximately 150°C, which corresponded to the loss of
physically adsorbed water in the glass network and ethanol evapora-
tion. The second and third peaks corresponded to the condensation
of silanol groups and the elimination of nitrates, which occurred at
390–430°C and 435–465°C, respectively. In addition, exothermic
peaks corresponding to the onset of crystallization for BG‐5/5
occurred around 1,000°C and 900°C, respectively.
XRD analysis of BG samples prior to immersion in SBF confirmed
its amorphous structure and glassy nature, as demonstrated by the
absence of characteristic peaks (Figure S1c). BG‐5/5 samples were
then immersed in SBF for 1, 3, 7, and 14 days. After 1 day of
MOGHANIAN ET AL.70immersion, the structure of BG surfaces remained amorphous as con-
firmed by the absence of the corresponding peaks in the XRD patterns
(Figure S1c). Diffraction peaks at 25.8 and 31.8 (2θ) corresponded to
(200) and (211) atomic planes in the apatite lattice, respectively,
according to standard Joint Committee on Powder Diffraction Stan-
dards cards (76‐0694). After 3 days of immersion, new peaks appeared
at 25.8 and 31.8 for BG‐5/5 (Figure S1c). After 7 days of immersion,
we observed a slight increase in the intensity of the peaks correspond-
ing to (200) and (211) for BG‐5/5 owing to the increase in apatite for-
mation. This was accompanied with the appearance of a peak at 31.8,
which corresponded to (211) atomic planes.3.2 | FTIR characterization and evaluation of ion
dissolution products
FTIR analysis was conducted in the range of 400–4,000 cm−1 with a
resolution of 8 cm−1 to evaluate apatite formation on the surface of
BG‐5/5 before and after immersion in SBF. Prior to immersion in
SBF, the FTIR spectrum of BG‐5/5 specimens revealed characteristic
bands corresponding to the silicate network, as demonstrated by the
prevalence of SiO2. Our results showed that all spectra exhibited sim-
ilar distributions regarding the positions of the different peaks of inter-
est (Figure S1d). For all immersion times, the main infrared bands
appeared at 470, 790, 922, 1,066, and 1,250 cm−1, which were related
to the Si–O–Si bending vibration, the Si–O symmetric stretching of
bridging oxygen atoms between tetrahedrons, Si–O stretching of
non‐bridging oxygen atoms, Si–O–Si symmetric stretching, and the
Si–O– Si asymmetric stretching, respectively (Figure S1d). The band
located at 609 cm−1 corresponded to the asymmetric vibration of
PO4
3−, whereas the stretching mode of the OH group appeared at
3,500 and 1,651 cm−1. Our results also revealed the appearance of
new peaks in the FTIR spectra, which confirmed the formation of apa-
tite on the surface of BG‐5/5 at later immersion (Figure S1d). For
instance, two additional peaks around 1,455 cm−1 and 870 cm−1 were
observed in the FTIR spectra for BG‐5/5, corresponding to C–O
stretching in carbonate groups, which were substituted by PO4
3−
groups in the apatite lattice after 3 days of immersion in SBF. In addi-
tion, the bands corresponding to the P–O absorption appeared as two
resolved peaks with increased intensity at 570 and 600 cm−1, which
are characteristic of crystalline apatite.
We used ICP‐OES analysis to investigate the concentrations of Ca,
Si, P, Sr, and Li ions, which were released from BG‐5/5 throughout dif-
ferent immersion times (i.e. 1, 3, 7, and 14 days) in SBF. Our results
showed that the concentration of Ca ions increased rapidly from
≈100 mg/l to ≈290.11 mg/l after 1 day of immersion (Figure S1e),
followed by a rapid decrease to≈124.24 mg/l at day 3. This behavior
could be explained in part due to the dissolution and precipitation of
Ca ions from the SBF onto the surface of the BG during the crystalli-
zation of HA. This observation further confirmed the results obtained
from the XRD and FTIR analyses, which showed no peaks indicative of
apatite formation after 1 day of immersion in SBF. In addition, ion
exchange between Ca, Sr, Li, and H, as well as increases in theconcentration of Li over time led to an increase in the pH during the
first days of immersion (Figure S1f). This was followed by a plateau
phase up to day 14, owing to the decrease in the soluble Ca concen-
tration in the SBF due to the formation of HA (Figure S1f; Mozafari,
Moztarzadeh, & Tahriri, 2010).3.3 | Synthesis and physical characterization of
GelMA‐BG‐5/5 composites
We first confirmed the cytocompatibility and ALP activity of the base
BG‐5/5 formulation in vitro, using MC3T3‐M1 preosteoblasts and
standard cytotoxicity and ALP activity assays (Figure S2). Our results
demonstrated that cells could proliferate in the presence of the BG
formulation (Figure S2a) and that the ALP activity increased consis-
tently up to 7 days of culture (Figure S2b). To form the composites,
different concentrations of BG‐5/5 (i.e., 1, 5, 10, and 20% [w/v]) were
mixed with 10% (w/v) GelMA precursor, followed by
photocrosslinking via visible light. We then characterized their physi-
cal properties including porosity, swellability, and degradability
in vitro. First, hydrogel composites were formed using cylindrical
molds (7‐mm diameter, 2‐mm height), freeze‐dried, and visualized
using SEM (Figure S1a–d). SEM micrographs revealed microstructures
of irregular and interconnected pores for all samples containing differ-
ent concentrations of BG‐5/5. In addition, the amount of dispersed
BG‐5/5 particles inside the polymeric network increased at higher
BG concentrations. However, hydrogels with 20% (w/v) BG‐5/5
exhibited significant particle aggregation, which prevented us from
acquiring quality images from these samples and thus, were excluded
from this analysis. We then determined the swellability of
GelMA/BG‐5/5 hydrogels by incubating the composites in DPBS at
37°C overnight. Our results demonstrated that the swelling ratio of
the composites after 24 hr increased consistently from
11.78 ± 0.77% to 30.02 ± 1.17% by increasing the concentration of
BG‐5/5 from 0% to 20%, respectively (Figure 1e). Similarly, our results
also showed that the degradation of the composites increased at
higher concentrations of BG, from 20.0 ± 0.47% at 0% to
31.43 ± 1.24% at 20%, after 21 days of incubation in DPBS.3.4 | Mechanical characterization
Hydrogel composites were synthesized by directly adding varying con-
centrations of BG‐5/5 (i.e. 1, 5, 10, and 20%) to the hydrogel precur-
sors, followed by photocrosslinking via visible light. Our results
showed that the compressive modulus of hydrogels increased from
142.49 ± 10.29 kPa to 511.83 ± 32.25 kPa and 757 ± 17.75 kPa when
BG‐5/5 concentration was enhanced from 0 to 10% and 20%, respec-
tively (Figure 2a‐b). Our results also showed that the elastic moduli
(Figure 2c) and the ultimate tensile strength (Figure 2d) of the compos-
ites increased concomitantly by increasing the concentration of BG‐5/
5. For instance, incorporation of 20% BG‐5/5 in GelMA prepolymer
increased the elastic modulus of the hydrogels from
122.47 ± 14.37 kPa (pristine GelMA hydrogel) to 383.4 ± 16.11 kPa
FIGURE 1 In vitro evaluation of porosity, swellability, and degradability of gelatin methacryloyl (GelMA)/ bioactive glass (BG)‐5/5 composites.
Representative scanning electron microscopy images of composites synthesized using 10% (w/v) GelMA and (a) 0%, (b) 1%, (c) 5%, and (d) 10%
(w/v) BG‐5/5 concentrations. (e) Swelling ratios and (f) degradation rates (change relative to the initial dry weight) of GelMA/BG‐5/5 composites
incubated in DPBS at 37°C. Data are represented as mean ± standard deviation (*p < .05, **p < .01, ***p < .001, ****p < .0001, and n ≥ 5) [Colour
figure can be viewed at wileyonlinelibrary.com]
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295.8 ± 10.29 kPa to 394.8 ± 21.01 kPa (Figure 2d). Moreover,
although hydrogels formed using 10% BG‐5/5 exhibited the highest
ultimate tensile strength (i.e., 436.69 ± 17.56 kPa), there were no sta-
tistically significant differences when compared with hydrogels syn-
thesized using 20% BG‐5/5.3.5 | In vitro evaluation of adhesive properties
We characterized the adhesive strength of GelMA/BG‐5/5 compos-
ites to physiological tissues using modified ASTM lap shear (Figure 3
a,b) and wound closure (Figure 3c,d) tests. Our results showed that
the shear strength of the composites increased consistently by
increasing the concentration of BG‐5/5 from 0% (i.e.,
409 ± 12.97 kPa) to 10% (i.e., 637.1 ± 10.24 kPa) (Figure 3b). How-
ever, hydrogels synthesized using 20% BG‐5/5 showed comparatively
lower shear strength (i.e., 508.78 ± 17.26 kPa). Our results for thewound closure tests showed a similar trend, with consistently higher
adhesive strengths to both bone (i.e., 208.7 ± 9.97 kPa, Figure 3c)
and skin (i.e., 260.48 ± 15.94 kPa, Figure 3d) for hydrogels synthesized
using 10% BG‐5/5. Because of this drop in their adhesive properties,
hydrogels containing 20% BG‐5/5 were excluded from subsequent
experiments involving cell surface seeding and 3D encapsulation. In
addition, the adhesive strength of the composites was significantly
higher than the commercial sealant, Evicel.3.6 | In vitro evaluation of cytocompatibility
Composite hydrogels were formed in cylindrical molds using 10 %
GelMA with 1, 5, and 10% BG‐5/5 as describe before, then seeded
with MC3T3 cells at a concentration of 2 × 106 cell/ml, and main-
tained in culture for 5 days (Figure 4). Pristine GelMA hydrogels were
used as controls. Cell viability (Figure 4a–h) and spreading (Figure 4i–
p) on the composites were then determined via a commercial
FIGURE 2 Mechanical characterization of gelatin methacryloyl (GelMA)/bioactive glass (BG)‐5/5 composites. (a) Representative compressive
stress‐strain curves, (b) compressive modulus, (c) elastic modulus, and (d) ultimate tensile strength of hydrogels synthesized using 10% (w/v)
GelMA and varying BG‐5/5 concentrations (i.e. 1, 5, 10, and 20%). Data are represented as mean ± standard deviation (*p < .05, **p < .01,
***p < .001, ****p < .0001, and n ≥ 5) [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 3 In vitro adhesive properties of gelatin methacryloyl/ bioactive glass (GelMA/BG) composite hydrogels. (a) Representative shear
strength‐strain curves, (b) shear strength, and (c,d) adhesive strength to porcine bone and skin for hydrogels synthesized using 10% (w/v)
GelMA and varying BG‐5/5 concentrations. Data are represented as mean ± standard deviation (*p < .05, **p < .01, ***p < .001, ****p < .0001, and
n ≥ 5) [Colour figure can be viewed at wileyonlinelibrary.com]
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FIGURE 4 2D seeding of MC3T3‐M1 cells on gelatin methacryloyl/bioactive glass (GelMA/BG)‐5/5 composites. MC3T3‐M1 cells were seeded
on the surface of composites synthesized using different concentrations of BG‐5/5 (i.e. 0, 1, 5, and 10%) and maintained in culture for 5 days.
Representative live/dead fluorescent micrographs of cells at days (a–d) 1 and (e–h) 5 post‐seeding. Representative F‐actin/DAPI fluorescent
micrographs of cells at days (i–l) 1 and (m–p) 5 post‐seeding. Quantification of (q) cell viability and (r) metabolic activity of MC3T3‐M1 cells grown
on the surface of composites synthesized using varying concentrations of BG‐5/5 at days 1, 3, and 5 post‐seeding (*p < .05, **p < .01, ***p < .001,
****p < .0001). Scale bars = 200 μm [Colour figure can be viewed at wileyonlinelibrary.com]
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MOGHANIAN ET AL.74LIVE/DEAD viability kit and fluorescent F‐actin/DAPI staining, respec-
tively. Our results showed that the composites could support the
attachment and proliferation of MC3T3‐M1 cells, as demonstrated
by F‐actin/DAPI fluorescent micrographs (Figure 4i–p). In addition,
cells remained >90% viable during the first 3 days of culture for all
conditions tested, with a slight drop in viability at day 5 post‐seeding
(Figure 4q). However, despite this relative drop in viability, the meta-
bolic activity of cells increased consistently up to 5 days post‐seeding,
as demonstrated by a commercial PrestoBlue assay (Figure 4r).
We also evaluated the ability of GelMA/BG‐5/5 composites to
support the growth and proliferation of 3D‐encapsulated MC3T3‐
M1 cells (Figure 5). For this, cells were mixed with the composite pre-
cursors at a density of 5 × 106 cell/ml and photocrosslinked on
3‐(trimethoxysilyl) propyl methacrylate‐coated glass slides. Cell‐laden
GelMA hydrogels containing 0 (control), 1, and 5% BG‐5/5 were also
prepared. Similar to 2D cultures, cell viability (Figure 5a–f) and spread-
ing (Figure 5g–l) within the composites were determined using a com-
mercial LIVE/DEAD viability kit and fluorescent F‐actin/DAPI staining,
respectively. Our results showed that overall, cells remained ≈90%
viable (Figure 5m) and exhibiting increasingly higher metabolic activity
(Figure 5n) up to 5 days post‐encapsulation. However, particle aggre-
gation for hydrogels with 10 and 20% (w/v) BG‐5/5 prevented the
homogeneous distribution of cells and BG particles within the scaf-
folds and thus, were not suitable for 3D encapsulation.3.7 | In vitro evaluation of osteoinductivity and
antimicrobial properties
MC3T3‐M1 cells were 3D encapsulated in 10% (w/v) GelMA
hydrogels containing 5% (w/v) BG‐5/5 and maintained in culture for
1, 2, and 3 weeks. We selected this formulation because it exhibited
comparatively better physical, mechanical, and tissue adhesive proper-
ties as compared to hydrogels containing 1% BG‐5/5 (w/v). Cells were
also encapsulated in pristine GelMA hydrogels with and without BMP‐
2 supplemented culture media to be used as controls. Visual inspec-
tion revealed consistently higher ECM deposition in GelMA/BG com-
posites, as demonstrated by the appearance of mineral crystals on the
scaffolds by weeks 2 and 3 post‐encapsulation (Figure 6a). Moreover,
pristine GelMA hydrogels without BMP‐2 supplementation became
increasingly softer and structurally weaker, which could be explained
in part due to the degradation of the scaffold and the lack of mineral-
ized ECM deposition from encapsulated cells. Histological assessment
of the scaffolds using Alizarin Red S (ALP) staining showed that
MC3T3‐M1 cells in GelMA/BG‐5/5 and BMP‐2‐supplemented GelMA
hydrogels exhibited consistently higher levels of calcium deposition,
when compared with pristine GelMA controls (Figure 6b). These
observations were further confirmed via quantitative image analysis
of the stained micrographs, which demonstrated that GelMA/BG‐5/
5 composites exhibited significantly higher levels of calcium deposi-
tion, when compared with both BMP‐2‐supplemented and pristine
GelMA controls (Figure 6c). In addition, visual inspection also revealed
significant differences in scaffold microarchitecture among theexperimental conditions tested. Pristine GelMA scaffolds showed
large pores and minimal calcium deposition, which correlated to their
comparatively weaker structural integrity (Figure 6b). In contrast, both
BMP‐2‐supplemented GelMA and GelMA/BG‐5/5 composites exhib-
ited smaller pores and significant calcium deposition, as demonstrated
by the higher red coloration in these scaffolds.
For the evaluation of the antimicrobial properties, MRSA bacteria
were grown directly on the composites, as well as pristine GelMA
hydrogels as a control. For this, we used scaffolds with 1% (w/v)
BG‐5/5 as reference, in order to evaluate the differences in antimicro-
bial properties at lower concentrations of BG. Our results demon-
strated that MRSA could readily colonize pristine GelMA scaffolds,
as indicated by the prominent green fluorescence (Figure 6d). In con-
trast, scaffolds synthesized using 1% (Figure 6e) and 5% (Figure 6f)
BG‐5/5 exhibited predominant red fluorescence, which was indicative
of the bactericidal activity of the composites.4 | DISCUSSION
Previous studies have reported the development of different BG formu-
lations for biomedical applications, such as BG‐58S, BG‐68S, and BG‐
77S (Hench & Jones, 2015; Jones, 2013; Ye, He, Wang, Yao, & Gou,
2014). Among these, BG‐58S is one of the most commonly used formu-
lations for boneTE owing to its remarkable biocompatibility and bioac-
tivity (Gong et al., 2014; Ji et al., 2017). Furthermore, the incorporation
of bivalent cations to the BG formulation has been shown to enhance
the mineralization and vascularization of the scaffold, while also
inhibiting the resorption of the newly formed bone (Drago et al.,
2018). Among these, Sr ions have been shown to inhibit osteoclast
activity, while also promoting the activity of osteoblasts for the forma-
tion of new bone (Hoppe & Boccaccini, 2015). Other studies have
shown that Sr exhibits mild bactericidal properties at the same concen-
trations that also up regulate osteoblast activity (Brauer et al., 2013). On
the other hand, Li plays a vital role in the proliferation and differentia-
tion of osteoblasts via upregulation of the Wnt pathway, which in turn
could enhance osteogenesis and accelerate bone healing in vivo
(Khorami, Hesaraki, Behnamghader, Nazarian, & Shahrabi, 2011). Fur-
thermore, Li has been shown to enhance bone formation while also
possessing immune‐stimulating and antimicrobial properties (Kavitha,
Subha, Shanmugam, & Kulandaivelu, 2014; Miguez‐Pacheco et al.,
2016). However, although Sr and Li have been used as doping elements
in existing formulations of BGs, the simultaneous incorporation of Sr
and Li into a SiO2‐CaO‐P2O5 system has not been explored. We have
recently developed and optimized a series of new BG formulations,
among which the formulation consisting of 60SiO2‐26CaO‐4P2O5‐
5SrO‐5Li2O (mol. %; termed BG‐5/5) showed the highest
cytocompatibility and ALP activity (Moghanian, Firoozi, Tahriri, &
Sedghi, 2018). Here, we aimed to characterize the physicochemical
properties of BG‐5/5, as well as the feasibility of incorporating this BG
formulation into GelMA hydrogels to yield bioactive and antimicrobial
adhesive hydrogels for bone repair. For this, we first characterized the
thermal behavior of BG‐5/5 (Figure S1a,b). Our results showed no
FIGURE 5 3D encapsulation of MC3T3‐M1 cells in gelatin methacryloyl/bioactive glass (GelMA/BG)‐5/5 composites. MC3T3‐M1 cells were
encapsulated inside composites synthesized using different concentrations of BG‐5/5 (i.e., 0, 1, and 5%) and maintained in culture for 5 days.
Representative live/dead fluorescent micrographs of cells at days (a–c) 1 and (d–f) 5 post‐encapsulation. Representative F‐actin/DAPI fluorescent
micrographs of cells at days (g–i) 1 and (j–l) 5 post‐seeding. Quantification of (m) cell viability and (n) metabolic activity of MC3T3‐M1 cells grown
within the composites synthesized using varying concentrations of BG‐5/5 at Days 1, 3, and 5 post‐seeding (*p < .05, **p < .01, ***p < .001,
****p < .0001). Scale bars = 200 μm [Colour figure can be viewed at wileyonlinelibrary.com]
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FIGURE 6 In vitro evaluation of osteoinductivity and antimicrobial properties of gelatin methacryloyl/bioactive glass (GelMA/BG)‐5/5
composites. (a) Representative images of GelMA/BG‐5/5 composites with 3D encapsulated MC3T3‐M1 preosteoblasts at weeks 1, 2, and 3 of
culture. White arrows indicate the appearance of mineral crystals on the composites. (b) Histological evaluation (Alizarin red) of the osteogenic
differentiation of 3D encapsulated MC3T3‐M1 cells in GelMA, GelMA/BMP‐2, and GelMA/BG‐5/5 hydrogels at weeks 1, 2, and 3 post‐
encapsulation (Scale bar = 500 μm). (c) Quantitative image analysis of Alizarin Red S‐stained micrographs. (*p < .05, **p < .01, ***p < .001, and
****p < .0001). Representative fluorescent micrographs of the BacLight viability assay. Methicillin‐resistant Staphylococcus aureus bacteria were
grown on (d) GelMA hydrogel, (e) GelMA hydrogel with 1% BG‐5/5, and (f) GelMA hydrogel with 5% BG‐5/5 (Scale bar = 20 μm) [Colour figure
can be viewed at wileyonlinelibrary.com]
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ical reactions and the release of volatile products. Hence, 700°C was
selected as the temperature for stabilization of the BGs.
BGs promote osseointegration through the formation of an inter-
facial layer of carbonated HA that bonds with the native bone
in vivo. Moreover, the ionic dissolution products released from BGs
under physiological conditions have also been shown to mediate the
osteogenic differentiation of stem cells (Hoppe & Boccaccini, 2015).
This phenomenon can be evaluated in vitro via immersion in an acellu-
lar SBF, because it has an ion concentration similar to human plasma.
Therefore, we evaluated the ability of BG‐5/5 to promote the forma-
tion of an interfacial apatite layer in SBF in vitro via XRD and FTIR
analysis and the evaluation of ion dissolution products. XRD analysis
revealed that there was a gradual increase in the intensity of the peaks
for the (211) planes from day 7 up to day 14, which was indicative of
apatite formation on the surface of the BG (Figure S1c). Furthermore,
the maturity of the newly formed apatite layer on the surface of BG‐5/5 after 14 days was also demonstrated by the detection of new
peaks at 32.18 and 32.86, which corresponded to the crystallization
of (112) and (300) atomic planes in the apatite lattice, respectively.
The results of the XRD analysis were indicative of the bioactivity of
BG‐5/5, as demonstrated by the appearance of characteristic peaks
at (002) and (211) atomic planes in the apatite lattice at 25.8, 31.8
(2θ°), as well as peaks corresponding to (112) and (300) atomic planes.
These results were further confirmed by FTIR spectra (Figure S1d) and
the evaluation of ion dissolution products (Figure S1e,f), which further
confirmed the formation and the crystallinity of the newly formed HA
following immersion in SBF. We then aimed to form bioactive com-
posite hydrogels by combining BG‐5/5 with a highly cytocompatible
polymeric network, which could support the attachment and prolifer-
ation of progenitor cells that mediate bone repair in vivo.
Despite the intrinsic biological activity of BGs, an ideal scaffolding
biomaterial should mimic the porosity and interconnected architecture
of the native bone, which in turn could promote autologous tissue
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the highly hydrophilic nature of hydrogels allows the establishment of
a biomimetic microenvironment, excess water uptake by the hydrogel
has been shown to alter its physical properties and impair cell migra-
tion and neovascularization (Seeherman & Wozney, 2005). In addition,
the scaffolds should be able to be biodegraded at a rate that matches
the formation of new tissue and into nontoxic byproducts that could
be readily metabolized by the body. Hence, we evaluated the porous
microstructure of GelMA/BG‐5/5 composites, as well as their
swellability and degradation in vitro. SEM analysis revealed the forma-
tion of scaffolds comprised of a porous network of GelMA with
increasing amounts of dispersed BG‐5/5 particles at higher BG con-
centrations (Figure 1a–d). Our results also showed that increasing
the concentration of BG‐5/5 led to higher swelling capacity
(Figure 1e) and degradation (Figure 1f) in vitro. Taken together, these
results suggested that the incorporation of higher concentrations of
BG‐5/5 into GelMA may reduce the crosslinking density between
polymer chains, which may lead to the formation of less compact
hydrogel networks with higher water uptake and degradation rates
in vitro. In contrast, previous groups have reported that the incorpora-
tion of different types of bioceramics into hydrogel‐based composites
often led to a reduction in pore size and swellability of the scaffold
(Killion et al., 2013; Liu et al., 2008; Peter et al., 2010). This character-
istic is important because smaller pores and a lower water uptake
could impair the cell migration and the adequate colonization of the
scaffold.
Collagen and its derivative gelatin have shown great potential for
bone TE owing to their ability to promote angiogenesis, wound
healing, and osteogenesis in vivo (Bai et al., 2018). However, these
polymers often exhibit comparatively lower load bearing capacity
and elastic moduli, when compared with metallic and ceramic com-
pounds (Turnbull et al., 2018). To address this limitation, different
types of BGs have been incorporated into ECM‐based polymers to
produce composite coatings, fillers, or scaffolds with enhanced bioac-
tivity and mechanical performance (Bai et al., 2018; Killion et al.,
2013). However, the accurate recapitulation of the physical properties
of osseous tissues remains challenging owing to their remarkable
mechanical stiffness. For instance, previous groups have reported that
the compressive and tensile strength of human cortical bone range
between 90 and 230 MPa and from 90 to 190 MPa, respectively;
whereas the compressive strength of trabecular bone ranges between
2 and 45 MPa (Barinov & Komlev, 2011). Therefore, alternative
approaches have been explored based on the use of low modulus
matrices, which can foster cell proliferation and osteogenic differenti-
ation through bioinspired approaches that drive scaffold mineraliza-
tion and maturation in vivo (Jha, Jackson, & Healy, 2014). The
mechanical characterization of GelMA/BG‐5/5 composites demon-
strated that increasing BG‐5/5 concentrations led to consistently
higher compressive stress (Figure 2a) and compressive moduli
(Figure 2b). Although these observations were in agreement with pre-
vious studies that have shown that the mechanical properties of soft
polymeric matrices could be increased through the incorporation of
inorganic BG fillers (Neumann & Epple, 2006; Sarker, Hum, Nazhat,& Boccaccini, 2015), these values were not in the range of the native
bone. However, we envisioned that GelMA/BG‐5/5 hydrogels could
be used instead to establish a regenerative interfacial niche with the
host tissues (Kirkpatrick, 2015). This is mainly because the intrinsic
bioactivity of the composites could drive the osteogenic differentia-
tion of migratory mesenchymal stem cells, which in turn could mediate
the mineralization and maturation of the scaffold in vivo (Huang,
Kobayashi, Liu, & Li, 2016). Therefore, although the ability of these
composites to be used as load bearing constructs is limited, GelMA‐
5/5 hydrogels hold remarkable potential to be used as bioactive scaf-
folds and coating materials that promote bone regeneration and tissue
integration in vivo.
We characterized the ability of the composites to bind to physio-
logical tissues, which is directly related to the therapeutic efficacy of
the scaffolds and their in vivo integration (Figure 3). Our results
showed a consistent increase in shear (Figure 3b) and adhesive
strengths (Figure 3c,d) at higher BG concentrations, up to 10% (w/v).
However, although the adhesive strength of 20% BG‐5/5 hydrogels
was comparatively lower than that of 10% BG‐5/5 hydrogels, there
were no statistically significant differences between these two condi-
tions. This drop in the adhesive properties and the ultimate tensile
strength at 20% BG‐5/5 could be explained in part due to the direct
interference of BG particles on the formation of the hydrogel network
during photocrosslinking. Therefore, we selected the formulations
containing 1, 5, and 10% BG‐5/5 for subsequent experiments. Fur-
thermore, our results also showed that the adhesive strength of the
composites was significantly higher than the commercially available
fibrin‐based sealant, Evicel, to both bone (Figure 3c) and skin
(Figure 3d) for all BG‐5/5 concentrations tested. Taken together,
these results highlight the potential of the composites to be used as
bioactive adhesive coatings that can be photocrosslinked in situ and
adhere strongly to the host tissues.
Apart from soluble and insoluble bioactive cues that are present in
the physiological microenvironment, the promotion of osteogenic
responses depends strongly on the direct interaction of osteoblasts
or osteoblast‐like cells with the composites. Therefore, we evaluated
the cytocompatibility and osteoinductivity of GelMA/BG‐5/5 com-
posites via 2D surface seeding (Figure 4) and 3D encapsulation
(Figure 5) of MC3T3‐M1 preosteoblasts, respectively. Taken together,
these results confirmed the in vitro cytocompatibility of the compos-
ites, as shown by their ability to efficiently support the growth ad pro-
liferation of MC3T3‐M1 cells in both 2D and 3D culture conditions.
Moreover, these results also showed that the metabolic activity of
MC3T3‐M1 preosteoblasts increased consistently throughout the
experiment, which was indicative of cells undergoing active replication
and protein synthesis (Figure 5n).
BGs provide several technical advantages for bone TE, which are
mainly associated with their ability to bind strongly to the native bone,
as well as to recruit bone‐forming cells that mediate the deposition of
osseous ECM components. Hence, we evaluated the ability of the
composites to promote the differentiation of 3D encapsulated
preosteoblasts in vitro. Previous groups have demonstrated the ability
of growth factors such as BMP‐2 to induce osteogenic differentiation
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other groups have explored the encapsulation of MC3T3‐M1 cells into
polymeric hydrogels with embedded bioactive cues such as nanostruc-
tured bone‐like HA (Demirtas, Irmak, & Gumusderelioglu, 2017), inor-
ganic polyphosphate chains (Wu et al., 2015), and different types of
BGs (Marelli et al., 2011; Zeng, Han, Li, & Chang, 2014). Here, we
hypothesized that the incorporation of BG‐5/5 into GelMA hydrogels
could yield a highly cytocompatible matrix with intrinsic osteogenic
activity. Histological evaluation confirmed the increased ECM deposi-
tion of MC3T3‐M1 cells in GelMA/BG‐5/5 hydrogels (Figure 6a–c).
This approach offers several advantages over conventional
approaches based on the delivery of osteogenic growth factors such
as BMP‐2. For instance, conventional delivery methods often suffer
from insufficient local retention and require the use of high protein
concentrations to achieve the desired biological effect in larger animal
models and humans (Vo, Kasper, & Mikos, 2012). In addition, uncon-
trolled delivery of growth factors could lead to severe side effects
owing to the use of supraphysiological concentrations of these mole-
cules. In contrast, our results demonstrated the intrinsic
osteoinductivity of the composites, based on the synergy between
the cell‐supportive properties of the polymeric GelMA network and
the bioactivity of the BG phase.
The development of bioactive scaffolds with antimicrobial proper-
ties has gained significant interest because orthopedic implant infec-
tions could lead to severe health complications such as septic
arthritis and osteomyelitis. Different pathogenic microorganisms,
including S. aureus, S. epidermidis, E. coli, and P. aeruginosa, have been
identified at the site of ≈90% of all orthopedic implants while also
exhibiting varying degrees of antibiotic resistance (Fernandes, Gentile,
Pires, Reis, & Hatton, 2017). In recent years, the emergence of
antibiotic‐resistant strains of pathogenic bacteria has brought forth
the need for antibiotic‐free strategies to prevent bacterial infections
that could lead to orthopedic implant failure. Therefore, local adminis-
tration of osteoinductive and antimicrobial agents that prevent bacte-
rial infections could represent a more convenient approach following
orthopedic procedures. We characterized the antimicrobial properties
of GelMA/BG‐5/5 composites using MRSA. Our results demonstrated
that the incorporation of increasing concentrations of BG‐5/5 led to
extensive bacterial death within the composites, as compared with
pristine GelMA controls (Figure 6d–f). These results were in agree-
ment with previous studies that have shown that BGs exhibit intrinsic
antimicrobial properties owing to the high pH and the osmotic effect
caused by their dissolution products. Moreover, the antimicrobial
activity of BGs has been demonstrated previously in vitro against aer-
obic and anaerobic pathogens, as well as some strains of antibiotic‐
resistant bacteria (Lepparanta et al., 2008; Munukka et al., 2008).
These results demonstrated the remarkable potential of GelMA/BG‐
5/5 hydrogels to be used for the treatment of orthopedic infections
without the need for local or systemic delivery of antibiotics.
In summary, our results demonstrated that GelMA/BG composites
constitute an attractive and cost‐effective strategy in the develop-
ment of osteogenic scaffolds, fillers, orthopedic implant coatings, and
other biomedical devices with increased therapeutic efficacy. This ismainly because the composite precursors could be delivered to bone
defects of any shape/size and photocrosslinked in situ to form an
osteoinductive and antimicrobial coating that can adhere to the native
bone to promote regeneration of the affected area. These multifunc-
tional composites present various technical advantages over conven-
tional approaches for the treatment and prevention of orthopedic
infections. For instance, the intrinsic bioactivity of the scaffolds could
promote osteoblastic differentiation of migratory mesenchymal stem
cells in vivo without the need for high doses of expensive growth fac-
tors, such as BMP‐2. The antimicrobial properties and the high adhe-
sive strength could prove remarkably advantageous for the
prevention of bacterial infections around orthopedic implants. In addi-
tion, the intrinsic ability of BGs to promote the formation of an inter-
facial apatite layer could promote osseointegration of the implant,
which would in turn increase its therapeutic efficacy. Lastly, the intrin-
sic angiogenic properties and the high number of cell‐binding domains
present in gelatin could promote neovascularization at the wound site
and enhanced bone repair. Future experiments include the molecular
characterization of the pathways involved in osteoblastic differentia-
tion, the characterization of the spectrum of antimicrobial activity with
different bacterial strains, integration into biofabrication techniques,
and the in vivo evaluation of the osteoinductive properties of the
scaffold.
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Table S1. Nominal composition of BG‐0 and BG‐5/5 (in mol. %)
Figure S1. Synthesis and molecular characterization of BG‐5/5. (a)
DTA and (b) TGA curves of BG‐5/5 up to 1100 °C. (c) The XRD pat-
terns of BG‐5/5 before immersion in SBF and after 1, 3, 7 and 14 days
of immersion in SBF. (d) The FTIR spectra of BG‐5/5 before and after
MOGHANIAN ET AL. 811, 3, 7, and 14 days of immersion in SBF. (e) Variation of elemental
concentration in the SBF at different immersion times for calcium
(Ca), silicon (Si), phosphorous (P), strontium (Sr), and lithium (Li). (f)
Changes in pH throughout 14 days of immersion of BG‐5/5 samples
in SBF.
Figure S2. In vitro evaluation of cytocompatibility and ALP activ-
ity of different formulations of BGs. (a) Quantification of
MC3T3‐E1 cell proliferation cultured on BG‐0, BG‐5/5, and con-
trol (no BG) samples after 1, 3 and 7 days using a commercial
3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide
(MTT) assay. (b) ALP activity of MC3T3‐E1 cells cultured onBG‐0, BG‐5/5 and control samples after 1, 3 and 7 days. Error
bars represented the mean ± standard deviation (SD) of measure-
ments (*p < 0.05, **p < 0.01 and ***p < 0.001).
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